Plot Twist: 80% of Clinical Trials DO NOT Miss Enrollment Timelines Because of Poor Recruitment
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
It’s a familiar story in clinical research: a referral comes through, the patient looks like a...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
ProofPilot’s acquisition of Lokavant is a move that will have a significant, high-value impact on...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
If you missed DPharm 2024, you also missed watching a live matchmaking event with Nichole Gallatti,...
There is nothing more important in clinical research execution than ensuring sites and patients...
Trial feasibility sometimes feels like a progressive game of bait and switch. In other words, early...
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...